Mangalam Drugs & Organics Limited
NSE: MANGALAM BSE: MANGALAM
NSE
81.80
2.06 (2.58%)
Prev Close
79.74
Open Price
80.9
Volume
58,922
Today Low / High
79.5 / 84.21
52 WK Low / High
70.1 / 144.99
Range
78 - 86
BSE
80.96
0.77 (0.96%)
Prev Close
80.19
Open Price
80.19
Volume
2,061
Today Low / High
79.79 / 84.19
52 WK Low / High
65.5 / 144.65
Range
77 - 85
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 81.8 (target range: 78 - 86), reflecting a change of 2.06 (2.5834%). On the BSE, it is listed at 80.96 (target range: 77 - 85), showing a change of 0.77 (0.96022%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
22 Aug
80.90
1.11%
21 Aug
81.47
-2.12%
20 Aug
81.01
-0.37%
19 Aug
80.60
1.86%
18 Aug
83.17
-2.16%
14 Aug
74.50
11.07%
13 Aug
75.60
-1.64%
12 Aug
79.00
-7.14%
11 Aug
78.39
-1.61%
08 Aug
77.98
-0.58%
07 Aug
85.57
-2.71%
06 Aug
89.84
-4.75%
05 Aug
90.85
-2.92%
04 Aug
89.82
-0.17%
01 Aug
88.42
0.29%
31 Jul
89.94
-1.45%
30 Jul
90.60
-1.88%
29 Jul
86.65
3.25%
28 Jul
89.22
-2.88%
Mangalam Drugs & Organics Limited Graph
Mangalam Drugs & Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Mangalam Drugs & Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 81.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 80.96 | 81.77 | 73.59 - 89.95 |
| 82.58 | 66.06 - 99.10 | ||
| 83.39 | 58.37 - 108.41 | ||
| Bearish Scenario | 80.96 | 80.15 | 72.14 - 88.17 |
| 79.34 | 63.47 - 95.21 | ||
| 78.53 | 54.97 - 102.09 |
Overview of Mangalam Drugs & Organics Limited
ISIN
INE584F01014
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
41,964
Market Cap
1,294,746,760
Last Dividend
0
Official Website
IPO Date
2005-05-23
DCF Diff
89.00
DCF
-7
Financial Ratios Every Investor Needs
Stock Dividend of MANGALAM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2017-12-21 | December 21, 17 | 0.5 | 0.5 | 2017-12-22 | 2017-12-29 | 2017-12-12 |
| 2011-09-20 | September 20, 11 | 2 | 2 | |||
| 2006-09-19 | September 19, 06 | 0.2 | 0.2 | |||
| 2005-08-30 | August 30, 05 | 0.2 | 0.2 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 317.58 Cr | 167.37 Cr | 150.21 Cr | 0.4730 | 0.00 Cr | 0.00 Cr | 19.22 Cr | 6.72 Cr | 4.25 | 35.82 Cr | 0.0212 |
| 2024-03-31 | 367.35 Cr | 348.54 Cr | 18.81 Cr | 0.0512 | 0.00 Cr | 9.51 Cr | 1.05 Cr | -9.07 Cr | -5.73 | 13.99 Cr | -0.0247 |
| 2023-03-31 | 370.20 Cr | 341.42 Cr | 28.78 Cr | 0.0777 | 0.00 Cr | 9.25 Cr | 14.97 Cr | 1.27 Cr | 0.80 | 25.95 Cr | 0.0034 |
| 2022-03-31 | 447.37 Cr | 392.68 Cr | 54.69 Cr | 0.1222 | 0.00 Cr | 7.77 Cr | 38.81 Cr | 19.66 Cr | 12.42 | 45.18 Cr | 0.0439 |
| 2021-03-31 | 379.80 Cr | 282.13 Cr | 97.67 Cr | 0.2572 | 0.00 Cr | 6.24 Cr | 44.45 Cr | 27.97 Cr | 17.67 | 55.02 Cr | 0.0736 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.59 Cr | 366.42 Cr | 217.44 Cr | 148.9790 Cr | 96.23 Cr | 93.64 Cr | 138.80 Cr | 133.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 191.5994 Cr |
| 2024-03-31 | 1.19 Cr | 333.70 Cr | 197.91 Cr | 135.7930 Cr | 106.99 Cr | 105.81 Cr | 123.64 Cr | 129.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 164.0611 Cr |
| 2023-03-31 | 2.68 Cr | 359.63 Cr | 207.67 Cr | 151.9562 Cr | 88.55 Cr | 85.87 Cr | 137.47 Cr | 134.43 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 165.3575 Cr |
| 2022-03-31 | 1.95 Cr | 328.43 Cr | 177.86 Cr | 150.5614 Cr | 87.90 Cr | 85.96 Cr | 117.11 Cr | 129.21 Cr | 10.49 Cr | 0.00 Cr | 0.00 Cr | 130.1133 Cr |
| 2021-03-31 | 0.58 Cr | 264.11 Cr | 133.32 Cr | 130.7860 Cr | 69.71 Cr | 69.12 Cr | 58.59 Cr | 117.54 Cr | 0.00 Cr | 0.00 Cr | 0.22 Cr | 109.0776 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 42.5941 Cr | -19.4724 Cr | -21.7124 Cr | 22.3929 Cr | 1.4093 Cr | 2.5889 Cr | -20.2012 Cr | 6.7207 Cr | -6.7094 Cr | 0.0000 Cr | -15.1621 Cr |
| 2024-03-31 | 3.9126 Cr | -11.8274 Cr | 5.2267 Cr | -7.9201 Cr | -1.5011 Cr | 1.1796 Cr | -11.8327 Cr | -9.0717 Cr | 12.4869 Cr | 0.0000 Cr | 16.8876 Cr |
| 2023-03-31 | 39.5231 Cr | -22.1723 Cr | -16.6171 Cr | 11.6094 Cr | 0.7338 Cr | 2.6807 Cr | -27.9137 Cr | 2.2138 Cr | -3.8658 Cr | 0.0000 Cr | -20.3609 Cr |
| 2022-03-31 | 25.7091 Cr | -27.3257 Cr | 2.9793 Cr | -1.9599 Cr | 1.3627 Cr | 1.9469 Cr | -27.6690 Cr | 27.7330 Cr | 14.1411 Cr | 0.0000 Cr | -58.5180 Cr |
| 2021-03-31 | 27.5497 Cr | -31.2853 Cr | 2.6983 Cr | -3.8864 Cr | -1.0373 Cr | 0.5918 Cr | -31.4361 Cr | 39.5191 Cr | 2.7036 Cr | 0.0000 Cr | 6.2551 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 57.21 Cr | 45.73 Cr | 11.48 Cr | 0.2007 | -8.95 Cr | -13.80 Cr | -8.72 | -4.48 Cr | -0.2412 |
| 2025-03-31 | 72.78 Cr | 35.36 Cr | 37.41 Cr | 0.5141 | 5.45 Cr | 0.06 Cr | 0.04 | 9.61 Cr | 0.0008 |
| 2024-12-31 | 88.55 Cr | 50.93 Cr | 37.62 Cr | 0.4249 | 4.72 Cr | 1.29 Cr | 0.81 | 8.91 Cr | 0.0145 |
| 2024-09-30 | 79.75 Cr | 40.66 Cr | 39.09 Cr | 0.4901 | 4.73 Cr | 2.69 Cr | 1.70 | 8.84 Cr | 0.0337 |
| 2024-06-30 | 76.49 Cr | 40.41 Cr | 36.08 Cr | 0.4717 | 4.31 Cr | 2.68 Cr | 1.70 | 8.21 Cr | 0.0351 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.59 Cr | 0.00 Cr | 2.59 Cr | 39.07 Cr | 138.80 Cr | 198.98 Cr | 133.60 Cr | 366.42 Cr | 217.44 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -147.97 Cr |
| 2024-09-30 | 6.08 Cr | 0.00 Cr | 16.52 Cr | 1.10 Cr | 142.95 Cr | 200.97 Cr | 130.79 Cr | 364.11 Cr | 216.14 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.91 Cr | 0.00 Cr | 0.00 Cr | 0.91 Cr | 0.00 Cr | 0.00 Cr | -135.79 Cr |
| 2024-03-31 | 1.19 Cr | 0.00 Cr | 1.19 Cr | 29.49 Cr | 123.64 Cr | 176.00 Cr | 126.89 Cr | 333.70 Cr | 197.91 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 2.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 3.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,641.80 | ₹3,939,137,904,000.00 | ₹2,098,280.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,151.50 | ₹1,633,032,553,500.00 | ₹681,521.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,685.30 | ₹1,247,271,358,500.00 | ₹279,863.00 |
| Mankind Pharma Limited | MANKIND | ₹2,606.80 | ₹1,075,901,331,568.00 | ₹731,305.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,277.60 | ₹1,063,387,459,020.00 | ₹1,229,762.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.80 | ₹994,960,224,000.00 | ₹307,413.00 |
| Lupin Limited | LUPIN | ₹1,974.70 | ₹901,938,300,900.00 | ₹380,522.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,426.00 | ₹648,759,690,000.00 | ₹99,581.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.40 | ₹610,074,420,800.00 | ₹1,872,840.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,937.30 | ₹546,707,997,300.00 | ₹466,930.00 |
| Laurus Labs Limited | LAURUSLABS | ₹879.10 | ₹474,560,157,500.00 | ₹1,548,001.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,418.40 | ₹359,853,753,600.00 | ₹437,395.00 |
| Cohance Lifesciences Limited | COHANCE | ₹884.70 | ₹338,457,031,978.00 | ₹105,334.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,638.50 | ₹329,643,636,000.00 | ₹49,045.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,747.90 | ₹273,268,433,900.00 | ₹250,994.00 |
| Piramal Enterprises Limited | PEL | ₹1,167.70 | ₹264,691,900,600.00 | ₹183,898.00 |
| Eris Lifesciences Limited | ERIS | ₹1,768.70 | ₹240,909,320,900.00 | ₹37,828.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,479.40 | ₹240,371,432,600.00 | ₹246,819.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,433.00 | ₹210,825,000,000.00 | ₹11,150.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹974.60 | ₹191,570,299,800.00 | ₹29,498.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,888.00 | ₹178,181,651,200.00 | ₹28,474.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,083.00 | ₹172,501,323,000.00 | ₹140,398.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,168.10 | ₹164,800,966,770.00 | ₹172,510.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹882.45 | ₹158,055,619,500.00 | ₹259,072.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹458.50 | ₹111,252,274,000.00 | ₹945,550.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,581.50 | ₹109,248,951,100.00 | ₹46,177.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹851.90 | ₹83,308,067,710.00 | ₹36,218.00 |
| Strides Pharma Science Limited | STAR | ₹865.50 | ₹79,775,471,850.00 | ₹92,326.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹863.25 | ₹78,240,335,715.00 | ₹294,141.00 |
| FDC Limited | FDC | ₹474.65 | ₹77,277,766,500.00 | ₹198,253.00 |
| Innova Captab Limited | INNOVACAP | ₹911.35 | ₹52,151,939,956.00 | ₹70,484.00 |
| Suven Life Sciences Limited | SUVEN | ₹230.75 | ₹50,320,575,500.00 | ₹56,095.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹146.08 | ₹47,406,173,760.00 | ₹195,028.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹483.05 | ₹44,087,973,500.00 | ₹160,106.00 |
| Sequent Scientific Limited | SEQUENT | ₹175.85 | ₹44,021,409,750.00 | ₹240,104.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹772.20 | ₹39,165,289,020.00 | ₹31,316.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,358.20 | ₹39,002,269,800.00 | ₹5,512.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹363.25 | ₹36,425,983,500.00 | ₹39,528.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹502.80 | ₹35,400,036,240.00 | ₹9,585.00 |
| Hikal Limited | HIKAL | ₹254.90 | ₹31,429,424,900.00 | ₹3,140,867.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹631.60 | ₹30,413,434,800.00 | ₹53,855.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹96.82 | ₹28,419,284,140.00 | ₹848,541.00 |
| Alembic Limited | ALEMBICLTD | ₹105.52 | ₹27,095,636,534.00 | ₹249,022.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹49.03 | ₹26,866,184,620.00 | ₹2,369,065.00 |
| Indoco Remedies Limited | INDOCO | ₹279.55 | ₹25,787,900,445.00 | ₹12,570.00 |
Key Executives
Chairman & MD
Mr. Govardhan Murlidhar Dhoot
Gender: male
Year Born: 1953
Company Secretary & Compliance Officer
Ms. Anuradha Pandey
Gender: female
Year Born: 1993
President
Dr. Kamal Ishvarlal Vashi
Gender: Not Specified
Year Born: 1980
Senior Manager
Ms. Mansi Sidhinath Pathak
Gender: female
Year Born: 1979
Whole-Time Director
Mr. Brijmohan Murlidhar Dhoot
Gender: male
Year Born: 1951
Head of Purchase
Mr. Yaduraj Dhoot
Gender: male
Year Born: 2000
General Manager
Mr. Rakesh Sakikram Srivastava
Gender: male
Year Born: 1974
Chief Operating Officer
Ms. Krishnapriya Nawal
Gender: female
Year Born: 1985
General Manager
Dr. Bhanvesh Dinesh Naik
Gender: Not Specified
Year Born: 1979
FAQs about Mangalam Drugs & Organics Limited
Who is the CEO of the company?
The CEO is Govardhan Murlidhar Dhoot.
What is the current market price of the stock?
The current price is ₹81.80.
What is the 52-week price range?
The range is ₹70.1-144.99.
What is the market capitalization of the company?
The market capitalization is ₹129.47 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -13.26.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Mangalam Drugs & Organics Limited (ISIN: INE584F01014) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹129.47 crores and an average daily volume of 41,964 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.